BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is a promising modality for peritoneal carcinomatosis. Splenectomy is frequently required, however effect upon hematotoxicity is unknown. METHODS: 195 patients undergoing the procedure were evaluated and granulocyte colony stimulating factor administered for white blood cell counts <4.0. RESULTS: 52% of 195 underwent splenectomy; average white blood cell and platelet nadirs were 6.1,172. Non-splenectomy patients averaged white blood cell nadir 4.6, platelet nadir 164.1. Granulocyte colony stimulating factor administered in 29% of splenectomy, 43% of non-splenectomy (P=0.043). CONCLUSION: Splenectomy ameliorates hematotoxicity of hyperthermic intraperitoneal chemotherapy and significantly reduces post-operative granulocyte colony stimulating factor requirements.
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is a promising modality for peritoneal carcinomatosis. Splenectomy is frequently required, however effect upon hematotoxicity is unknown. METHODS: 195 patients undergoing the procedure were evaluated and granulocyte colony stimulating factor administered for white blood cell counts <4.0. RESULTS: 52% of 195 underwent splenectomy; average white blood cell and platelet nadirs were 6.1,172. Non-splenectomy patients averaged white blood cell nadir 4.6, platelet nadir 164.1. Granulocyte colony stimulating factor administered in 29% of splenectomy, 43% of non-splenectomy (P=0.043). CONCLUSION: Splenectomy ameliorates hematotoxicity of hyperthermic intraperitoneal chemotherapy and significantly reduces post-operative granulocyte colony stimulating factor requirements.
Authors: Syed A Ahmad; Joseph Kim; Jeffrey J Sussman; Debbie A Soldano; Linda J Pennington; Laura E James; Andrew M Lowy Journal: Ann Surg Oncol Date: 2004-04 Impact factor: 5.344
Authors: B Sadeghi; C Arvieux; O Glehen; A C Beaujard; M Rivoire; J Baulieux; E Fontaumard; A Brachet; J L Caillot; J L Faure; J Porcheron; J L Peix; Y François; J Vignal; F N Gilly Journal: Cancer Date: 2000-01-15 Impact factor: 6.860
Authors: D Elias; M Bonnay; J M Puizillou; S Antoun; S Demirdjian; Otmany A El; J P Pignon; L Drouard-Troalen; J F Ouellet; M Ducreux Journal: Ann Oncol Date: 2002-02 Impact factor: 32.976
Authors: John H Stewart; Perry Shen; Greg Russell; Joyce Fenstermaker; Libby McWilliams; Faith M Coldrun; Keith E Levine; Bradley T Jones; Edward A Levine Journal: Ann Surg Oncol Date: 2008-05-21 Impact factor: 5.344
Authors: Laura A Lambert; Terri S Armstrong; J Jack Lee; Suyu Liu; Matthew H G Katz; Cathy Eng; Robert A Wolff; Melissa L Tortorice; Pier Tansey; Santiago Gonzalez-Moreno; Donald H Lambert; Paul F Mansfield Journal: Ann Surg Oncol Date: 2009-05-28 Impact factor: 5.344
Authors: Konstantinos Votanopoulos; Chukwuemeka Ihemelandu; Perry Shen; John Stewart; Gregory Russell; Edward A Levine Journal: J Surg Res Date: 2012-03-10 Impact factor: 2.192
Authors: Carlos Pérez-Ruixo; Belén Valenzuela; José Esteban Peris; Pedro Bretcha-Boix; Vanesa Escudero-Ortiz; José Farré-Alegre; Juan José Pérez-Ruixo Journal: AAPS J Date: 2015-11-17 Impact factor: 4.009